Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.
about
Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients.Novel therapeutic strategies for alcohol and drug addiction: focus on GABA, ion channels and transcranial magnetic stimulationAcute and chronic administration of a low-dose combination of topiramate and ondansetron reduces ethanol's reinforcing effects in male alcohol preferring (P) rats.The efficacy of a low dose combination of topiramate and naltrexone on ethanol reinforcement and consumption in rat models.Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Substance Use and Related Disorders, Part 1: Alcoholism.Treatment of alcohol dependence with low-dose topiramate: an open-label controlled study.Nephrolithiasis in topiramate users.Pharmacoprophylaxis of alcohol dependence: Review and update Part II: EfficacyNew pharmacological approaches for the treatment of alcoholism.An overview of the development of medications including novel anticonvulsants for the treatment of alcohol dependence.Development of medications for alcohol use disorders: recent advances and ongoing challenges.Pregabalin- and topiramate-mediated regulation of cognitive and motor impulsivity in DBA/2 mice.The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical TrialsCaenorhabditis elegans as a Model to Study the Molecular and Genetic Mechanisms of Drug Addiction.Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence.Emerging drugs to treat alcoholism.Pharmacoprophylaxis of alcohol dependence: Review and update Part I: Pharmacology.Combined pharmacotherapies for the management of alcoholism: rationale and evidence to date.Pharmacotherapy of alcoholic liver disease in clinical practice.Use of Anti-Craving Agents in Soldiers with Alcohol Dependence Syndrome.Systems biology - old concepts, new science, new challengesEffects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes.Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.Identification of Novel Signal Transduction, Immune Function, and Oxidative Stress Genes and Pathways by Topiramate for Treatment of Methamphetamine Dependence Based on Secondary Outcomes.Incidence of kidney stones with topiramate treatment in pediatric patients.
P2860
Q24632593-F1C087C1-14CE-4267-B2EB-FAD90A0FBB7DQ26853630-38FEDD3D-2800-42B0-967E-7B566EA28B79Q30408317-9CE78CE5-2E11-43E1-8E3D-37DB1B785821Q30408902-B870F1BE-61A6-4A30-B15C-E190BAC052B3Q30412006-B40A49E9-56CE-4B90-9C92-5646CCEDD113Q30438009-6D92B6FC-1C79-448E-A36D-021CCAB1AE36Q30440516-12E554FA-F71D-441F-80AD-8D55DC187C67Q33319816-9D0983E9-2D0D-40BB-A006-2CB215D2AE6EQ33845389-2E53155B-033F-4DB6-9AF6-BBFD83F52F13Q33919910-635D8203-0A88-4176-B1A0-C5ACE482A1CEQ33974746-9847C6BC-F3CA-49E9-9401-F95F10F70D87Q34582243-1D8FC756-8A4D-41CC-A84C-3BB259406375Q35871868-3C61D9F8-740D-4C7F-8699-AFD4E25CE02EQ36150622-2783A6E5-F2D3-40BD-902C-620E40338BFEQ36252863-082FD179-A3E6-4617-A23C-F02DA0F3219FQ36717481-E2A2DF26-ABCB-4183-94D2-F04CA5FABF5CQ36807410-4D4B6A9F-F825-4295-B52D-76DC97C1E07AQ37410610-5756FCCC-DE59-49D6-A54C-B20D7CCACDD7Q37766239-52FE5AC6-2493-480C-B3CE-66346DC8A108Q37773792-3BB65621-19CE-4A39-A08A-B1D1A7B412CAQ38185313-0C00B700-3082-4987-A17E-332146E72CE8Q38681092-948E5B88-B73B-4FA2-8F36-688C99A37442Q41172386-0234EF51-B393-4EB1-960F-91EC5CD648A0Q42704649-1453D961-C67E-41E1-AED4-C9F86EE20EAAQ47898735-1D6C0F26-86F6-4D14-8F5C-6CF2F2140C36Q48383731-704BF5AD-FD02-41B5-9E71-C3523055A0CAQ49532909-50371C13-9FE0-4DB4-BDDB-7D70E6D3067BQ51419801-CD1B5332-BC4F-439C-A845-CAC4EA6A41AD
P2860
Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Progress in the development of ...... s to a proof-of-concept study.
@ast
Progress in the development of ...... s to a proof-of-concept study.
@en
type
label
Progress in the development of ...... s to a proof-of-concept study.
@ast
Progress in the development of ...... s to a proof-of-concept study.
@en
prefLabel
Progress in the development of ...... s to a proof-of-concept study.
@ast
Progress in the development of ...... s to a proof-of-concept study.
@en
P2860
P1476
Progress in the development of ...... s to a proof-of-concept study.
@en
P2093
Bankole A Johnson
P2860
P304
P356
10.1097/01.ALC.0000134533.96915.08
P577
2004-08-01T00:00:00Z